Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.48 USD | +7.08% | +8.07% | -32.30% |
11/06 | Transcript : Vistagen Therapeutics, Inc., Q4 2024 Earnings Call, Jun 11, 2024 | |
11/06 | Vistagen Therapeutics, Inc. Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.30% | 8.78Cr | |
+16.40% | 12TCr | |
+19.24% | 12TCr | |
+21.22% | 2.66TCr | |
-23.72% | 1.99TCr | |
-17.47% | 1.63TCr | |
-45.95% | 1.55TCr | |
-18.30% | 1.55TCr | |
+64.00% | 1.48TCr | |
+2.25% | 1.37TCr |
- Stock Market
- Equities
- VTGN Stock
- News Vistagen Therapeutics, Inc.
- Vistagen to Get Patent for Neuropathic Pain Treatment Candidate in Europe